1. Home
  2. IOBT vs POAS Comparison

IOBT vs POAS Comparison

Compare IOBT & POAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IO Biotech Inc.

IOBT

IO Biotech Inc.

HOLD

Current Price

$0.32

Market Cap

57.2M

Sector

Health Care

ML Signal

HOLD

POAS

Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

N/A

Current Price

$3.63

Market Cap

49.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
IOBT
POAS
Founded
2014
2017
Country
Denmark
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
57.2M
49.3M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
IOBT
POAS
Price
$0.32
$3.63
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$2.25
N/A
AVG Volume (30 Days)
27.2M
1.0M
Earning Date
11-14-2025
02-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$128,328.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$2.90
52 Week High
$2.79
$4.30

Technical Indicators

Market Signals
Indicator
IOBT
POAS
Relative Strength Index (RSI) 37.51 53.07
Support Level $0.30 $2.99
Resistance Level $0.58 $3.65
Average True Range (ATR) 0.09 0.24
MACD -0.02 0.04
Stochastic Oscillator 27.08 67.03

Price Performance

Historical Comparison
IOBT
POAS

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

About POAS Phaos Technology Holdings (Cayman) Limited Class A Ordinary Shares

Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.

Share on Social Networks: